SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,952.25 25.20
(0.05%)

Dow Jones

7,687.74 15.20
(0.20%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

95.92 -0.05
(-0.05%)

EUR-INR

108.79 -0.10
(-0.09%)

GBP-INR

127.19 0.21
(0.17%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Zenotech Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532039

INE486F01012

15.5858074

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

256.27

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	43.61	43.05	40.83	42.42	36.57	22.45
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	43.61	43.05	40.83	42.42	36.57	22.45
Other Income	2.31	3.47	1.00	1.08	0.63	0.41
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	45.92	46.52	41.83	43.50	37.20	22.86
EXPENDITURE :
Raw Materials	0.00	0.84	0.00	0.06	0.00	0.03
Power & Fuel Cost	3.24	2.71	2.69	3.79	3.25	3.12
Employee Cost	15.53	12.38	9.46	7.88	7.10	6.49
Other Manufacturing Expenses	11.96	9.52	8.70	7.67	6.66	4.67
Selling & Administrative Expenses	2.85	2.85	2.33	2.00	1.91	1.62
Miscellaneous Expenses	1.05	0.57	0.43	0.31	0.19	0.13
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	34.62	28.87	23.61	21.72	19.10	16.06
Operating Profit	11.30	17.65	18.23	21.79	18.09	6.79
Interest	0.00	0.00	0.00	0.11	1.22	1.55
Gross Profit	11.30	17.65	18.23	21.68	16.87	5.24
Depreciation	7.11	6.96	7.09	7.17	6.97	6.46
Profit Before Tax	4.19	10.69	11.14	14.51	9.90	-1.22
Tax	0.49	2.49	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.77	2.59	2.84	2.92	-12.27	0.00
Reported Net Profit	-1.07	5.61	8.30	11.59	22.18	-1.22
Extraordinary Items	0.03	2.73	-0.03	0.03	0.00	0.00
Adjusted Net Profit	-1.10	2.88	8.33	11.56	22.18	-1.22
Adjustment below Net Profit	0.06	-0.02	-0.03	0.04	0.06	-0.01
P & L Balance brought forward	-174.44	-180.03	-188.30	-199.93	-222.17	-220.94
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-175.45	-174.44	-180.03	-188.30	-199.93	-222.17
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.18	0.92	1.36	1.90	3.63	-0.20
Earnings Per Share(Adj)-Unit Curr	-0.18	0.92	1.36	1.90	3.63	-0.20
Book Value-Unit Curr	15.59	15.75	14.84	13.48	11.57	7.93
Book Value(Adj)-Unit Curr	15.59	15.75	14.84	13.48	11.57	7.93

71,909.70 -570.59 ( -0.79%)

50,952.25 25.20 (0.05%)

7,687.74 15.20 (0.20%)

68,256.51 -700.21 (-1.02%)

10,455.36 27.09 (0.26%)

95.92 -0.05 (-0.05%)

108.79 -0.10 (-0.09%)

127.19 0.21 (0.17%)

0.61 0.00 (0.14%)